Manufacturing Challenges in Regenerative Medicine

See allHide authors and affiliations

Science Translational Medicine  16 Apr 2014:
Vol. 6, Issue 232, pp. 232fs16
DOI: 10.1126/scitranslmed.3008558

You are currently viewing the abstract.

View Full Text


Along with scientific and regulatory issues, the translation of cell and tissue therapies in the routine clinical practice needs to address standardization and cost-effectiveness through the definition of suitable manufacturing paradigms.

View Full Text